Prognostic and diagnostic value of circRNA expression in prostate cancer: A systematic review and meta-analysis

BackgroundCircular RNAs (circRNAs) are receiving increasing attention as novel biomarkers. Our goal was to investigate the diagnostic, clinicopathological, and prognostic utility of circRNAs in prostate cancer (PCa).MethodsRelevant literature was searched in PubMed, Web of Science, and EMBASE. Sensi...

Full description

Bibliographic Details
Main Authors: Jingling Xie, Hui Jiang, Yuanqing Zhao, Xin rui Jin, Baolin Li, Zixin Zhu, Limei Zhang, Jinbo Liu
Format: Article
Language:English
Published: Frontiers Media S.A. 2022-11-01
Series:Frontiers in Oncology
Subjects:
Online Access:https://www.frontiersin.org/articles/10.3389/fonc.2022.945143/full
_version_ 1798043882133389312
author Jingling Xie
Hui Jiang
Yuanqing Zhao
Xin rui Jin
Baolin Li
Zixin Zhu
Limei Zhang
Jinbo Liu
author_facet Jingling Xie
Hui Jiang
Yuanqing Zhao
Xin rui Jin
Baolin Li
Zixin Zhu
Limei Zhang
Jinbo Liu
author_sort Jingling Xie
collection DOAJ
description BackgroundCircular RNAs (circRNAs) are receiving increasing attention as novel biomarkers. Our goal was to investigate the diagnostic, clinicopathological, and prognostic utility of circRNAs in prostate cancer (PCa).MethodsRelevant literature was searched in PubMed, Web of Science, and EMBASE. Sensitivity, specificity, diagnostic odds ratio (DOR), negative likelihood ratio (NLR), positive likelihood ratio (PLR), and the area under the curve (AUC) were calculated to evaluate the diagnostic accuracy of circRNA expression. circRNAs’ clinical, pathological, and prognostic value was examined using pooled odds ratios (ORs) and hazard ratios (HRs).ResultsThis meta-analysis included 23 studies, with 5 for diagnosis, 16 for clinicopathological parameters, and 10 for prognosis. For diagnostic value, the pooled sensitivity, pooled specificity, PLR, NLR, DOR, and AUC were 0.82, 0.62, 2.17, 0.29, 7.37, and 0.81, respectively. Upregulation of carcinogenic circRNAs was associated with poor clinical parameters (Gleason score: OR = 0.222, 95% CI: 0.145–0.340; T classification: OR = 0.274, 95% CI: 0.175–0.430; lymph node metastasis: OR = 0.353, 95% CI: 0.175–0.716; tumor size: OR = 0.226, 95% CI: 0.099–0.518) and could predict poor survival outcomes (HR = 2.408, 95% CI: 1.559–3.720, p < 0.001). Conversely, downregulation of tumor-suppressor circRNAs was also associated with poor clinical parameters (Gleason score: OR = 1.689, 95% CI: 1.144–2.493; T classification: OR = 2.586, 95% CI: 1.779–3.762) and worse prognosis (HR = 1.739, 95% CI: 1.147–2.576, p = 0.006).ConclusionOur results showed that circRNAs might be useful biomarkers for the diagnosis and prognosis of PCa.Systematic review registrationhttps://www.crd.york.ac.uk/prospero/, identifier CRD42021284785.
first_indexed 2024-04-11T22:56:11Z
format Article
id doaj.art-43b3e811808947f2b818734170f831fe
institution Directory Open Access Journal
issn 2234-943X
language English
last_indexed 2024-04-11T22:56:11Z
publishDate 2022-11-01
publisher Frontiers Media S.A.
record_format Article
series Frontiers in Oncology
spelling doaj.art-43b3e811808947f2b818734170f831fe2022-12-22T03:58:25ZengFrontiers Media S.A.Frontiers in Oncology2234-943X2022-11-011210.3389/fonc.2022.945143945143Prognostic and diagnostic value of circRNA expression in prostate cancer: A systematic review and meta-analysisJingling XieHui JiangYuanqing ZhaoXin rui JinBaolin LiZixin ZhuLimei ZhangJinbo LiuBackgroundCircular RNAs (circRNAs) are receiving increasing attention as novel biomarkers. Our goal was to investigate the diagnostic, clinicopathological, and prognostic utility of circRNAs in prostate cancer (PCa).MethodsRelevant literature was searched in PubMed, Web of Science, and EMBASE. Sensitivity, specificity, diagnostic odds ratio (DOR), negative likelihood ratio (NLR), positive likelihood ratio (PLR), and the area under the curve (AUC) were calculated to evaluate the diagnostic accuracy of circRNA expression. circRNAs’ clinical, pathological, and prognostic value was examined using pooled odds ratios (ORs) and hazard ratios (HRs).ResultsThis meta-analysis included 23 studies, with 5 for diagnosis, 16 for clinicopathological parameters, and 10 for prognosis. For diagnostic value, the pooled sensitivity, pooled specificity, PLR, NLR, DOR, and AUC were 0.82, 0.62, 2.17, 0.29, 7.37, and 0.81, respectively. Upregulation of carcinogenic circRNAs was associated with poor clinical parameters (Gleason score: OR = 0.222, 95% CI: 0.145–0.340; T classification: OR = 0.274, 95% CI: 0.175–0.430; lymph node metastasis: OR = 0.353, 95% CI: 0.175–0.716; tumor size: OR = 0.226, 95% CI: 0.099–0.518) and could predict poor survival outcomes (HR = 2.408, 95% CI: 1.559–3.720, p < 0.001). Conversely, downregulation of tumor-suppressor circRNAs was also associated with poor clinical parameters (Gleason score: OR = 1.689, 95% CI: 1.144–2.493; T classification: OR = 2.586, 95% CI: 1.779–3.762) and worse prognosis (HR = 1.739, 95% CI: 1.147–2.576, p = 0.006).ConclusionOur results showed that circRNAs might be useful biomarkers for the diagnosis and prognosis of PCa.Systematic review registrationhttps://www.crd.york.ac.uk/prospero/, identifier CRD42021284785.https://www.frontiersin.org/articles/10.3389/fonc.2022.945143/fullcircular RNAsprostate cancerdiagnosisprognosisclinicopathological features
spellingShingle Jingling Xie
Hui Jiang
Yuanqing Zhao
Xin rui Jin
Baolin Li
Zixin Zhu
Limei Zhang
Jinbo Liu
Prognostic and diagnostic value of circRNA expression in prostate cancer: A systematic review and meta-analysis
Frontiers in Oncology
circular RNAs
prostate cancer
diagnosis
prognosis
clinicopathological features
title Prognostic and diagnostic value of circRNA expression in prostate cancer: A systematic review and meta-analysis
title_full Prognostic and diagnostic value of circRNA expression in prostate cancer: A systematic review and meta-analysis
title_fullStr Prognostic and diagnostic value of circRNA expression in prostate cancer: A systematic review and meta-analysis
title_full_unstemmed Prognostic and diagnostic value of circRNA expression in prostate cancer: A systematic review and meta-analysis
title_short Prognostic and diagnostic value of circRNA expression in prostate cancer: A systematic review and meta-analysis
title_sort prognostic and diagnostic value of circrna expression in prostate cancer a systematic review and meta analysis
topic circular RNAs
prostate cancer
diagnosis
prognosis
clinicopathological features
url https://www.frontiersin.org/articles/10.3389/fonc.2022.945143/full
work_keys_str_mv AT jinglingxie prognosticanddiagnosticvalueofcircrnaexpressioninprostatecancerasystematicreviewandmetaanalysis
AT huijiang prognosticanddiagnosticvalueofcircrnaexpressioninprostatecancerasystematicreviewandmetaanalysis
AT yuanqingzhao prognosticanddiagnosticvalueofcircrnaexpressioninprostatecancerasystematicreviewandmetaanalysis
AT xinruijin prognosticanddiagnosticvalueofcircrnaexpressioninprostatecancerasystematicreviewandmetaanalysis
AT baolinli prognosticanddiagnosticvalueofcircrnaexpressioninprostatecancerasystematicreviewandmetaanalysis
AT zixinzhu prognosticanddiagnosticvalueofcircrnaexpressioninprostatecancerasystematicreviewandmetaanalysis
AT limeizhang prognosticanddiagnosticvalueofcircrnaexpressioninprostatecancerasystematicreviewandmetaanalysis
AT jinboliu prognosticanddiagnosticvalueofcircrnaexpressioninprostatecancerasystematicreviewandmetaanalysis